1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

Antithrombotic Therapy after Acute Coronary Syndromes Antithrombotic therapy is a central
component of treatment after acute coronary syndromes. The focus is on antiplatelet therapy …

Abstract Background Oral anticoagulants (OACs) mitigate stroke risk in patients with atrial
fibrillation (AF). The study aim was to analyze prevalence and predictors of OAC …

Abstract Up to 10% of the> 3 million Americans with atrial fibrillation will experience an acute
coronary syndrome or undergo percutaneous coronary intervention. Therefore, concurrent …

Background: We performed a meta-analysis to evaluate the effects of dual antithrombotic
treatment (DATT) including direct oral anticoagulants (OAs) versus triple antithrombotic …

Objective The aim of the study was to assess current management of patients with atrial
fibrillation (AF) and acute coronary syndrome (ACS) undergoing coronary stenting. Design …

Coronary artery disease exhibits growing mortality and morbidity worldwide despite the
advances in pharmacotherapy and coronary intervention. Coronary artery disease is …

Six randomised controlled trials (RCTs) testing double versus triple antithrombotic therapy
(ATT)[1–6] in patients with atrial fibrillation (AF) and with concomitant acute coronary …

Atrial fibrillation (AF) represents the most prevalent supraventricular arrhythmia in adults
population and up to 15% of AF patients undergo percutaneous coronary intervention (PCI) …

Selecting anticoagulation therapy for patients with atrial fibrillation and coronary artery
disease has always been challenging for physicians. The treatment modalities have evolved …